Financhill
Back

Actinium Pharmaceuticals, Inc. Stock Price Chart

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
50

ATNM
Actinium Pharmaceuticals, Inc.

Last Price:
$1.70
Seasonality Move:
102.85%

7 Day Trial

ALL ACCESS PASS

$ 7
  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ATNM is experiencing buying pressure, which is a positive indicator for future bullish movement.

Actinium Pharmaceuticals, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 1.55 Buy
20-day SMA: 1.46 Buy
50-day SMA: 1.44 Buy
200-day SMA: 1.52 Buy
8-day EMA: 1.57 Buy
20-day EMA: 1.49 Buy
50-day EMA: 1.47 Buy
200-day EMA: 1.69 Buy

Actinium Pharmaceuticals, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.06 Buy
Relative Strength Index (14 RSI): 64.7 Buy
Chaikin Money Flow: 159656 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.34 - 1.54) Buy
Bollinger Bands (100): (1.41 - 1.67) Buy

Actinium Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Actinium Pharmaceuticals, Inc. Stock

Is Actinium Pharmaceuticals, Inc. Stock a Buy?

ATNM Technical Analysis vs Fundamental Analysis

Sell
50
Actinium Pharmaceuticals, Inc. (ATNM) is a Sell

Is Actinium Pharmaceuticals, Inc. a Buy or a Sell?

Actinium Pharmaceuticals, Inc. Stock Info

Market Cap:
52.7M
Price in USD:
1.69
Share Volume:
220.8K

Actinium Pharmaceuticals, Inc. 52-Week Range

52-Week High:
2.41
52-Week Low:
1.03
Sell
50
Actinium Pharmaceuticals, Inc. (ATNM) is a Sell

Actinium Pharmaceuticals, Inc. Share Price Forecast

Is Actinium Pharmaceuticals, Inc. Stock a Buy?

Fundamental Analysis of Actinium Pharmaceuticals, Inc.

Is Actinium Pharmaceuticals, Inc. a good investment?

  • Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.35 per share, and an increase next year of $0.34 per share.

Technical Analysis of Actinium Pharmaceuticals, Inc.

Should I short Actinium Pharmaceuticals, Inc. stock?

* Actinium Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.